About AbbVie
AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peoples lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womens health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
Functional Description:
NBE Pharmaceutical Sciences US - Focused on the development of NCEs and NBEs candidates by applying formulation sciences, innovative technologies, R&D; executional excellence and teamwork.
Key Deliverables:
1. Perform a literature review of the current nanotechnologies being employed at the pharmaceutical industry for improvement of poor solubility and thus, bioavailability of small-molecule drugs. Assess available biopharmaceutical technologies, including nanoparticle-based, for the development of high concentration biologics for subcutaneous and IV administration.
2. Build an internal database of potential TPMs focused on the development and manufacturing of nanoparticulate formulations. Determine based on their capacities and expertise the work required to bring those development and manufacturing capabilities in-house.
3. Establish verbal and/or written communication with potential TPMs for assessing their technical expertise in nanoparticle formulation development, GMP manufacturing and analytical characterization.
Qualifications
Preferred Qualifications:
* Must be a team player and work well in a collaborative environment
* Must have strong time management skills and be able to effectively prioritize
* Critical thinker; ability to assess and solve problems independently with minimal guidance
* Proactive and results-driven mindset; self-starter
* Strong written and verbal communication skills
* Experienced in basic business tools such as Excel, Power Point, and Word
* This role requires strong organizational, strategic thinking, analytical and interpersonal skills.
* Any coursework or research experience in Engineering/Science majors such as Chemical OR Pharmaceutical OR Biomedical, on these topics:
* Pharmaceutical sciences
* Polymer science and technology
* Drug delivery
* Biomaterials engineering
Minimum Qualifications:
* Minimum GPA = 3.0/4.0
* Returning to university for at least one semester and graduating within one-year post internship
* Currently enrolled in university, pursuing a Bachelors degree with a major in Chemical Engineering, Pharmaceutical Sciences, Biomedical Engineering or other related field of study
* Demonstrated leadership skills (i.e. extracurricular activities or projects)
* Must be authorized to work in the US on a permanent basis without requiring sponsorship
Significant Work Activities
Continuous sitting for prolonged periods (more than 2 consecutive hours in an 8 hour day)
Travel
No
Job Type
Internship
Schedule
Full-time
Job Level Code
IC
Equal Employment Opportunity
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.
Chicago, IL
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.
Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.